AT1

3.85%

2.5¢ atomo diagnostics limited

Ann: Access Bio receives FDA clearance for COVID-19 antibody test, page-48

First 48 Last

Share
Profile

Follow
zoltar

444 Posts.

48

29/06/21

08:46

Post #: 54134570
Share

Originally posted by danhoff: ↑

I did not say that. People who have HAD covid should be able to say - via a test, I have antibodies therefore I dont need a vaccine and I still qualify as a 'vaccinated' (that is an antibodied) person. That is, on the vaccine, health passports that the govts said they would not implement, but they are now implementing

To follow the logic of what is going on, step by step, is really not that hard.

Now, if the greedy and braindeads in govt, big pharma, medical inbred institutions actually recogonised that antibodies obtained (naturally) by those who recovered from covid were valid protection, it would mean a huge market for the Atomo test.

It is very simple, if you HAD covid and have antibodies do you actually need the vaccine. Is the risk of harm more than the risk of (extra) benefit... to get a vaccine on top of already existing natural antibodies (and I see the AccessBio strip can even identify the antibodies from alpha, beta, and deta variants... if I read the annoucements correctly)

Now, let us take this another step. Let us say the inbred, medical system tell us 'getting a vaccine for those who already had covid is good'. They actually do say that. Well, how about getting Astra and Pfizer and J&J and Sputic and Xi-special vaccines one after the other. I mean if one is good and two is better, then I guess three is better, etc etc.

Now enter the recent chat re BOOSTERs (vaccine jab 3). Also noted in the annoucement. AccessBio bravely ask 'if our test can show you have antibodies, maybe you do not NEED the booster'. Dare I ask about Booster 4 and Booster 5 and Booster x+1.

Surely, surely a human brain with the tiniest focus can SEE the merry path we are being led down.

Would it not be great if an antibody test could SHOW you have the antibodies already. And you can avoid a jab, currently.

Remember how we have a problem with overperscribed antibiotics. Will there end up being a problem having over perscribed vaccines.

I wonder if my above thoughts are allowed to be expressed. I would not want to irritate a non-thinking wokie somewhere (well, I actually am challenging humans to use their brains and not be sheepled around).

My entire thought is re Atomo at this stage. Would it not be great if our kit can be used for diagnostics. To SEE what is in your blood - without sending to a lab giving big $$$ to the very inbred system we are trying to assist.

Expand

hey mate, don't waste your time trying to explain yourself! since yesterday a lot of people started to write on AT1 for the single purpose to make it look like it's being discussed more and more. for the classical pump. Plus many people don't want to use their brains and are happy to follow the dinosaurus regarding vaccines... few days/weeks ago the AZ vaccine was administered to 60+ (from 50+) before that and today is "good" for everyone ... if this is not stupidity at it's best I don't know how to define it.

Last edited by zoltar: 29/06/21

AT1 Price at posting: 19.0¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

RCE

Recce's R327 found effective against E.coli during clinical trial

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

There are more pages in this discussion • 3 more messages in this thread...

First 48 Last

Add AT1 (ASX) to my watchlist

(20min delay)
Last 2.5¢		Change -0.001(3.85%)		Mkt cap ! $15.98M

Open	High	Low	Value	Volume
2.6¢	2.6¢	2.5¢	$15.57K	604.4K

Buyers (Bids)

No.	Vol.	Price($)
4	277067	2.5¢

Sellers (Offers)

Price($)	Vol.	No.
2.7¢	18145	1

View Market Depth

No.	Vol.	Price($)
2	235200	0.025
2	150461	0.024
2	493000	0.023
5	438874	0.022
3	555000	0.021

Price($)	Vol.	No.
0.027	18145	1
0.028	306666	3
0.029	252248	7
0.030	841593	11
0.031	159930	3

Last trade - 15.57pm 28/06/2024 (20 minute delay)

AT1 (ASX) Chart

Ann: Access Bio receives FDA clearance for COVID-19 antibody test, page-48

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Ava Risk Group expands US presence with A$0.7M Substation Deal

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Recce's R327 found effective against E.coli during clinical trial

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Access Bio receives FDA clearance for COVID-19 antibody test, page-48

Top Stories

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Ava Risk Group expands US presence with A$0.7M Substation Deal

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Recce's R327 found effective against E.coli during clinical trial

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News